INTAM_Network
@INTAM_Network
Followers
241
Following
126
Media
30
Statuses
155
The Official Twitter Account of International Networks of tES /TMS Trials for Addiction Medicine (INTAM) @INTAM_Network
Joined February 2020
If you’re interested in TMS for substance use disorder comorbid with depression, don’t miss this workshop by Kathleen Brady, @EkhtiariHamed , and @victormarktang — it covers all the essential points you need to know. #AAAP2025
https://t.co/yYKk0nzKgG
youtube.com
36th Annual Meeting and Scientific Symposium. Workshop title: How to Use rTMS for Comorbid Substance Use Disorder and Major Depressive Disorder: Practical Co...
0
1
3
Repetitive Transcranial Magnetic Stimulation (#rTMS) in Substance Use Disorders is Safe and Tolerable: A Systematic Review of 141 Clinical Trials Including 4,299 Participants @INTAM_Network
https://t.co/dWiVe30tx1
medrxiv.org
Background Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive neuromodulation intervention that has been investigated as a treatment for substance use disorder (SUD) and its...
0
2
11
🌟Delighted to share Colleen Hanlon (@brainstimgrl)'s talk at #NYCN2024 (@NYUNeuromod)! 🧠 Her insightful presentation on "Challenges in Academic & #NIH-funded Neuromodulation Trials from the #Industry Point of View" is a must-watch. Check it out:
0
0
0
🌟 Delighted to share @its_abhidatta’s talk at #NYCN2024 (@NYUNeuromod)! 🧠 His presentation, "Working with the FDA to Design a Trial" provides key insights into shaping #addiction #neuromodulation #trials in collaboration with the #FDA. 🔗 Watch here:
0
0
1
🌟 Delighted to share Leonardo Angelone's talk at #NYCN2024, @NYUNeuromod! 🧠 Dive into #Neuromodulation gants with his presentation: "NIDA SBIR/STTR Grant Opportunities in Neuromodulation" Don't miss out on the latest funding opportunities! 🔗 Watch now:
0
0
1
🌟 Delighted to share Will M. Aklin's talk at #NYCN2024, hosted by @NYUNeuromod! 🧠 Discover groundbreaking #opportunities in #Addiction and #Neuromodulation as he presents: "Program Priorities on Neuromodulatory Devices in DTMC/NIDA" 🔗 Watch it here:
0
2
3
🌟 Delighted to share John Fedota’s talk from #NYCN2024! 🧠 Discover more opportunities in #addiction research and #neuromodulation with his presentation: "NIDA Behavioral and Cognitive Neuroscience Neuromodulation Funding Opportunities" 🔗 Watch now:
0
1
1
NYC Addiction Neuromodulation Forum 2024 videos are now out and available for use for anyone who is interested in knowing updates on the development of treatments for drug addiction using brain stimulation: @UMN_MDTA @neuromodec
https://t.co/L69sKL1vDQ
https://t.co/tBVgccAPiV
youtube.com
This forum brought together professionals from academia, industry, NIH, and FDA to delve into the transformative potential of brain stimulation technologies ...
0
20
57
✨Delighted to share @EkhtiariHamed’s talk at #NYCN2024! 🧠 Dive into groundbreaking advancements in #addiction #neuromodulation with "Where Are We in Addiction Neuromodulation?" exploring the journey so far and future directions. 🔗Watch now:
0
4
7
Exciting news!🚀The @INTAM_network community is coming together at #CPDD2023 to discuss the latest advancements in #tES and #TMS for #AddictionMedicine. Join us and be a part of this transformative event!🙌 🗓️Date: 6/20/2023 ⏰Time: 5:30-6:30 PM 📍Location: Governor's Square 11
1
0
6
📢 We’re hosting a series of free, live webinars with @UMN_MDTA to discuss Dose Response in Non-Invasive Brain Stimulation. 📅 Thurs 3 Nov & Thurs 10 Nov, 10:00 AM - 12:00 PM ET 💰 Free registration: Webinar 1: https://t.co/rt9PAMQfyT Webinar 2: https://t.co/ZAbR7meIos
0
36
75
Great joy to talk w/ @foxmdphd about the Center for Brain Circuit Therapeutics @BWHNeurology @harvardmed, lesion network mapping and similar techniques! Guest q by @boeslab, @shansiddiqi, @neuromichael, @fredschaper3 & @danieltcorp! 🙏 Tune in here: https://t.co/kFGbYqCva0
1
23
62
A new #systematic_review and #meta_analysis with a total of 13 papers included, evaluated the effects of #rTMS on #drug #craving, #depression, #anxiety, #sleep, and #cognitive function in individuals with #methamphetamine use disorder. https://t.co/tQOm0DeYtt
journals.sagepub.com
Objective To evaluate the effects of rTMS on drug craving, depression, anxiety, sleep, and cognitive function in methamphetamine (MA) dependent individuals. Da...
0
3
3
A new #TMS study provides evidence that increasing the duration and intensity of #rTMS over the left #dlPFC appear to have greater effects on #delay_discounting rates, with a small effect on participant burden. https://t.co/5H43KYKkGo
frontiersin.org
Background: Repetitive transcranial magnetic stimulation (rTMS) is a novel treatment for smoking cessation and delay discounting rate is novel therapeutic ta...
0
3
3
Would #tDCS over #DLPFC modulate #cue_induced #craving? A new tDCS study on #methamphetamine users shows that brain regions with the highest electric current density modulated response to cue exposure. https://t.co/5j2xHHjqfU
onlinelibrary.wiley.com
In this experimental RCT among methamphetamine users, the activation and connectivity differences induced by active transcranial electrical stimulation over prefrontal cortex compared to sham...
0
2
8
We have exciting ideas to share if you are attending #WCP2022 by @WPA_Psychiatry in person or online and interested in @INTAM_Network activities. https://t.co/j7dKBqDCuS
wcp-congress.com
Join us at the 26th World Congress of Psychiatry (WCP 2026), which will take place from 23-26 September 2026, in Stockholm, Sweden.
📢The #WCP2022 by @WPA_Psychiatry is around the corner and ISAM will be present with 2 exciting sessions, featuring @EkhtiariHamed, @baldacchinoa1, @VerdejoGAntonio, @ParnianRafei, & Prof Marc Potenza! Not in Bangkok? the sessions will be streamed online: https://t.co/Z8RgLHARlU
0
0
2
One session of frontal-parietal-temporal #cathodal #tDCS can significantly reduce daily #cigarette consumption for at least 48 hours in #smokers with a history of #heroin use. https://t.co/IsLSxrFb6w
0
1
1
A #TMS study shows that #iTBS treatments can enhance behavioral #inhibition in #heroin use disorder. Suggested improved behavioral inhibition can affect #cue_induced #craving and be a predictive factor of treatment outcome. https://t.co/ceUqvISnIV
0
0
1
A new insight into the similar therapeutic effect of #iTBS over the left #DLPFC compared with 10 Hz #rTMS in treating patients with #MUD. Both 10 Hz and iTBS could reduce the #cue_induced_craving and improve #withdrawal symptoms in patients with MUD. https://t.co/7X4TCE9OX7
0
1
5
A new meta-analysis reveals that #iTBS has a greater positive effect than 10-Hz #rTMS in patients with #MUD, and the effect correlates with an increased proportion of women. https://t.co/2rdb2cbgxE
frontiersin.org
Background: Repetitive transcranial magnetic stimulation (rTMS) has demonstrated therapeutic potential for treating patients with methamphetamine use disorde...
0
1
1